High Expression of a Cancer Stemness-Related Gene, Chromobox 8 (CBX8), in Normal Tissue Adjacent to the Tumor (NAT) Is Associated with Poor Prognosis of Colorectal Cancer Patients
- PMID: 35681547
- PMCID: PMC9180723
- DOI: 10.3390/cells11111852
High Expression of a Cancer Stemness-Related Gene, Chromobox 8 (CBX8), in Normal Tissue Adjacent to the Tumor (NAT) Is Associated with Poor Prognosis of Colorectal Cancer Patients
Abstract
Background: Several studies have demonstrated that the molecular profile of normal tissue adjacent to the tumor (NAT) is prognostic for recurrence in patients with different cancers. This study investigated the clinical significance of CBX8 gene expression, a cancer stemness-related gene, in tumor and NAT tissue of colorectal cancer (CRC) patients.
Methods: The gene level of CBX8 in paired CRC and NAT specimens from 95 patients was determined by quantitative PCR. CBX8 protein level in CRC and NAT specimens from 66 patients was determined by immunohistochemistry. CBX8 gene and protein levels were correlated with the patients' clinicopathological parameters and circulatory immune cell profiles. The association between CBX8 and pluripotency-associated genes was analyzed using the TCGA database.
Results: NAT CBX8 gene level positively correlated with TNM stage, tumor invasion, lymph node metastasis and distant metastasis, indicating its association with tumor progression and metastasis. There was no correlation between NAT CBX8 protein level and clinicopathological parameters. Moreover, a high level of CBX8 gene and protein in NAT both correlated with poor DFS and OS. There was an inverse correlation between CBX8 gene level and post-operative platelet counts and platelet to lymphocyte level, suggesting its association with systematic inflammation. Finally, TCGA analysis showed that CBX8 level was correlated with a couple of pluripotency-associated genes, supporting its association with cancer stemness.
Conclusions: High NAT CBX8 is a poor prognostic factor for tumor progression and survival in CRC patients.
Keywords: CBX8; colorectal cancer; normal tissue adjacent to the tumor (NAT); prognostic biomarker.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- Allemani C., Weir H.K., Carreira H., Harewood R., Spika D., Wang X.S., Bannon F., Ahn J.V., Johnson C.J., Bonaventure A., et al. Global surveillance of cancer survival 1995–2009: Analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet. 2015;385:977–1010. doi: 10.1016/S0140-6736(14)62038-9. - DOI - PMC - PubMed
-
- Schneider S., Park D.J., Yang D., El-Khoueiry A., Sherrod A., Groshen S., Streeter O., Iqbal S., Danenberg K.D., Lenz H.J. Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation. Pharm. Genom. 2006;16:555–563. doi: 10.1097/01.fpc.0000220563.44724.6d. - DOI - PubMed
-
- Kuan J.C., Wu C.C., Sun C.A., Chu C.M., Lin F.G., Hsu C.H., Kan P.C., Lin S.C., Yang T., Chou Y.C. DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: Evidence from a clinical cohort study. PLoS ONE. 2015;10:e0123396. doi: 10.1371/journal.pone.0123396. - DOI - PMC - PubMed
-
- Grassi A., Perilli L., Albertoni L., Tessarollo S., Mescoli C., Urso E.D.L., Fassan M., Rugge M., Zanovello P. A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer. Mol. Cancer. 2018;17:17. doi: 10.1186/s12943-018-0770-8. - DOI - PMC - PubMed
-
- Pan Q., Qin F., Yuan H., He B., Yang N., Zhang Y., Ren H., Zeng Y. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma. Cancer Med. 2021;10:3139–3152. doi: 10.1002/cam4.3890. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases